A 136.43 (+0.55%)
US00846U1016Medical Diagnostics & ResearchDiagnostics & Research

Agilent Technologies (A) Competitor Comparison

We are evaluating the key criteria listed to compare Agilent Technologies (A) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - A ranking 48 / 58

These are the competitors of Agilent Technologies in the industry Diagnostics & Research ranked by linearity 10 years
1. Guardant Health GH
105.22
2. Anixa Biosciences ANIX
38.25
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. National Research NRC
18.96
5. Illumina ILMN
11.54
6. Neogen NEOG
10.23
7. Olink Holding OLK
8.11
8. Global Cord Blood CO
5.67
9. Fulgent Genetics FLGT
5.44
10. DarioHealth DRIO
4.86
11. Sera Prognostics SERA
4.55
12. Inotiv NOTV
4.39
13. Sotera Health SHC
4.12
14. Pacific Biosciences of California PACB
3.97
15. Syneos Health SYNH
3.71
16. Bioventus BVS
3.58
17. Myriad Genetics MYGN
3.52
18. Co-Diagnostics CODX
3.21
19. Enzo Biochem ENZ
3.08
20. Exact Sciences EXAS
3
21. Qiagen QGEN
2.75
22. Psychemedics PMD
2.71
23. Exagen XGN
2.39
24. CareDx CDNA
2.28
25. Aspira Womens Health AWH
2.28
26. Meridian Bioscience VIVO
2.1
27. Twist Bioscience TWST
2.09
28. MDxHealth MDXH
2.04
29. Biodesix BDSX
1.95
30. MaxCyte MXCT
1.91
31. Personalis PSNL
1.9
32. bioAffinity Technologies BIAF
1.9
33. NeoGenomics NEO
1.84
34. Charles River Laboratories CRL
1.81
35. Prenetics Global PRE
1.77
36. Quest Diagnostics DGX
1.68
37. Organovo Holdings ONVO
1.66
38. Neuronetics STIM
1.62
39. Trinity Biotech TRIB
1.57
40. Laboratory Corp of America Holdings LH
1.45
41. SeqLL SQL
1.42
42. Interpace Biosciences IDXG
1.27
43. IQVIA Holdings IQV
1.18
44. PerkinElmer PKI
1.15
45. Precipio PRPO
1.09
46. Icon ICLR
1.09
47. DexCom DXCM
0.95
48. Agilent Technologies A
0.94
49. Mettler-Toledo MTD
0.88
50. IDEXX Laboratories IDXX
0.83
51. Waters WAT
0.8
52. Thermo Fisher Scientific TMO
0.77
53. Danaher DHR
0.77
54. Heska HSKA
0.52
55. Natera NTRA
0.44
56. RadNet RDNT
0.41
57. Lantheus Holdings LNTH
0.33
58. Medpace Holdings MEDP
0.22

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.

If you accept cookies, we use them to improve and personalize your experience. Manage Cookies